D-1525-2019 Class II Terminated

Recalled by Geritrex, LLC — Middletown, NY

FDA drug recall D-1525-2019 was initiated by Geritrex, LLC on May 31, 2019 and is designated Class II. Reason for recall: cGMP Deviations: Products may have microbial contamination. The recall status is terminated (terminated Feb 2, 2024). Affected quantity: 7653 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 31, 2019
Initiation Date
May 31, 2019
Termination Date
Feb 2, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7653 bottles

Product description

Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941

Reason for recall

cGMP Deviations: Products may have microbial contamination.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 70611, Exp 6/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1525-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1525-2019. Report a data issue: hello@regdatalab.com.